Southern California Pharmacists Expanding Their Role

By John Norton

An intriguing example of how pharmacist-driven pilot programs are helping to reinvent health care is contained in the Los Angeles Times’ article by Soumya Karlamangla called “Pharmacists try a more personal approach to treatment”. Continue reading ‘Southern California Pharmacists Expanding Their Role’

Medicare Part D Any Willing Pharmacy Legislation Supported by Key Consumer Organizations

By Michael Rule

Recently, a dozen patient rights and consumer-oriented organizations sent a letter to Congress endorsing H.R. 793, the Ensuring Seniors Access to Local Pharmacies Act. Continue reading ‘Medicare Part D Any Willing Pharmacy Legislation Supported by Key Consumer Organizations’

Bills Address NCPA Member Priorities

By Michael Rule

The 114th Congress convened just over a month ago, yet it has been an eventful time for independent community pharmacies as legislation has been introduced to address all three of our top priorities as identified by a recent NCPA member survey.

Continue reading ‘Bills Address NCPA Member Priorities’

Patients, Pharmacists Share Problems with Aetna/Coventry 2015 Medicare Drug Plans

By Kevin Schweers

Community pharmacists and some Medicare beneficiaries reported a number of problems in early January related to changes to the pharmacy network of 2015 Aetna/Coventry Medicare Part D plans. Continue reading ‘Patients, Pharmacists Share Problems with Aetna/Coventry 2015 Medicare Drug Plans’

Senators back more MTM in Medicare drug plans

By Kevin Schweers

A bipartisan report from the Senate Aging Committee focuses on how to increase utilization of generic drugs to lower costs and specifically suggests expanded eligibility for medication therapy management (MTM) services, such as from community pharmacists. Continue reading ‘Senators back more MTM in Medicare drug plans’

The “Lock-In” Pharmacy Approach to Rx Drug Abuse

By Kevin Schweers

A proposal to restrict certain Medicare beneficiaries to use only a dedicated, “lock-in” pharmacy for their controlled substances is now a part of legislation introduced by two House lawmakers. Continue reading ‘The “Lock-In” Pharmacy Approach to Rx Drug Abuse’

Senate Hearing Scheduled on Generic Drug Price Spikes

By Kevin Schweers

Senator Bernie Sanders (I-Vt.), Chairman of the Senate Subcommittee on Primary Health and Aging, announced that his panel will hold a hearing on Nov. 20 to “explore why the costs of certain generic drugs are skyrocketing.” NCPA appreciates the subcommittee’s work and will continue to support their efforts to address this issue.

Continue reading ‘Senate Hearing Scheduled on Generic Drug Price Spikes’


Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Search by Categories


Follow

Get every new post delivered to your Inbox.

Join 494 other followers